{"id":48876,"date":"2025-08-06T06:36:19","date_gmt":"2025-08-06T06:36:19","guid":{"rendered":"https:\/\/www.newsbeep.com\/ca\/48876\/"},"modified":"2025-08-06T06:36:19","modified_gmt":"2025-08-06T06:36:19","slug":"are-wall-street-analysts-bullish-on-baxter-international-stock","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ca\/48876\/","title":{"rendered":"Are Wall Street Analysts Bullish on Baxter International Stock?"},"content":{"rendered":"\n<p class=\"yf-1090901\">Valued at a market cap of\u00a0$11.3 billion, Baxter International Inc. (BAX) is a global healthcare and medtech company headquartered in Deerfield, Illinois. It specializes in medical products and pharmaceuticals focused on intravenous (IV) therapy, surgical care, anesthesia, drug compounding, and connected healthcare systems.<\/p>\n<p class=\"yf-1090901\">Shares of BAX have lagged behind the broader market over the past 52 weeks.\u00a0BAX has fallen 39%\u00a0over this time frame, while the broader S&amp;P 500 Index ($SPX) has\u00a0gained 14.5%. Moreover, Baxter International stock has dipped 24.7% on a YTD basis, trailing SPX&#8217;s 6.1% upstick.<\/p>\n<p class=\"yf-1090901\">Looking closer, the medical products maker has also struggled to keep up with the Health Care Select Sector SPDR Fund&#8217;s (XLV)\u00a013.3% drop\u00a0over the past 52 weeks and 4.7% plunge in 2025.<\/p>\n<p>    <img fetchpriority=\"high\" decoding=\"async\" src=\"data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/ywAAAAAAQABAAACAUwAOw==\" alt=\"www.barchart.com\" loading=\"eager\" height=\"527\" width=\"782\" class=\"yf-1gfnohs loader\"\/> www.barchart.com      <\/p>\n<p class=\"yf-1090901\">On Jul. 31, Baxter posted its second-quarter earnings, and its shares dipped 22.4% as the company lowered its full-year guidance, projecting EPS of $2.42\u2013$2.52, citing ongoing operational headwinds and cautious hospital spending. It reported revenue of $2.81 billion, up 4% year-over-year and in line with guidance, while adjusted EPS rose 28% to $0.59.<\/p>\n<p class=\"yf-1090901\">For the current fiscal year, ending in December 2025, analysts expect\u00a0BAX\u2019s EPS to grow 31.8% year-over-year\u00a0to $2.49. The company\u2019s earnings surprise history is mixed. It beat the consensus estimates in three of the last four quarters, while missing on one occasion.<\/p>\n<p class=\"yf-1090901\">Among the 15 analysts covering the stock, the\u00a0consensus rating\u00a0is a \u201cModerate Buy.\u201d That\u2019s based on four \u201cStrong Buy\u201d ratings, ten \u201cHolds,\u201d and one \u201cModerate Sell.\u201d<\/p>\n<p>    <img decoding=\"async\" src=\"data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/ywAAAAAAQABAAACAUwAOw==\" alt=\"www.barchart.com\" loading=\"lazy\" height=\"691\" width=\"787\" class=\"yf-1gfnohs loader\"\/> www.barchart.com      <\/p>\n<p class=\"yf-1090901\">This configuration is less bullish than a month ago, with five \u201cStrong Buy\u201d ratings on the stock.<\/p>\n<p class=\"yf-1090901\">On August 1, Wells Fargo &amp; Company (WFC) analyst Larry Biegelsen maintained an &#8220;Equal-Weight&#8221; rating on Baxter International but sharply cut the price target from $33 to $24, a 27.3% reduction, reflecting a more cautious outlook on the stock.<\/p>\n<p class=\"yf-1090901\">BAX\u2019s mean price target of $36.21 implies a 64.9% from the current market prices. The Street-high price target of $42 implies a robust potential upside of 91.3% from the current price levels.<\/p>\n<p class=\"yf-1090901\"> On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally\u00a0published on <a href=\"https:\/\/www.barchart.com\/story\/news\/33854749\/are-wall-street-analysts-bullish-on-baxter-international-stock?utm_source=yahoo&amp;utm_medium=syndication&amp;utm_content=footer_link\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Barchart.com;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">Barchart.com<\/a> <\/p>\n","protected":false},"excerpt":{"rendered":"Valued at a market cap of\u00a0$11.3 billion, Baxter International Inc. (BAX) is a global healthcare and medtech company&hellip;\n","protected":false},"author":2,"featured_media":48877,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[33520,49,48,33521,84,33523,392,33522],"class_list":["post-48876","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-baxter-international-inc","tag-ca","tag-canada","tag-global-healthcare","tag-health","tag-health-care-select-sector-spdr-fund","tag-healthcare","tag-healthcare-systems"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/48876","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/comments?post=48876"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/48876\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media\/48877"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media?parent=48876"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/categories?post=48876"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/tags?post=48876"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}